Danaher Corp (DHR)

$161.91 -2.63 (-1.60%)
Market Cap 114.60B
Revenue (ttm) 24.57B
Net Income (ttm) 3.61B
EPS (ttm) N/A
PE Ratio 20.62
Forward PE 19.51
Profit Margin 14.71%
Debt to Equity Ratio 0.33
Volume 4,053,900
Avg Vol 4,572,454
Day's Range N/A - N/A
Shares Out 707.77M
Stochastic %K 6%
Beta 0.81
Analysts Strong Sell
Price Target $245.47

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cultu...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
accretivewealth
accretivewealth May. 15 at 2:19 PM
$DHR Apparently, there is no bottom. Sometimes the market sends a message. Management does not always listen.
1 · Reply
accretivewealth
accretivewealth May. 14 at 6:56 PM
$DHR worse than paint drying, paint peeling here
0 · Reply
Wallstfan
Wallstfan May. 14 at 5:58 PM
$DHR here we go again, selling off back to red
0 · Reply
11thestate
11thestate May. 14 at 2:33 PM
$DHR — Danaher Corporation Agreed to Settle With Investors Danaher Corporation has agreed to settle $172.5 million with investors regarding its bioprocessing business, COVID-related demand assumptions, and repeated guidance cuts. The agreement has already been submitted to the court for final approval. The settlement aims to compensate affected shareholders. If you purchased $DHR between January 27, 2022, and October 23, 2023, you may be eligible to file a claim and recover part of your losses. You can review the details and submit your claim here: https://11th.com/cases/danaher-investor-settlement
2 · Reply
Wallstfan
Wallstfan May. 14 at 1:00 PM
$DHR great company on sale. If it’s not tech there just selling everything. At some point the rotation will come. Slowly taking a position here.
1 · Reply
dka79
dka79 May. 14 at 11:51 AM
$DHR reversal coming ?
1 · Reply
HedgeFollow
HedgeFollow May. 14 at 11:23 AM
🔍 𝗡𝗲𝘄 13𝗙 𝗥𝗲𝗹𝗲𝗮𝘀𝗲𝗱 🔎 Outstanding Hedge Fund Manager Alex Klabin of Senator Group made some Notable trades in Q1: 𝗡𝗲𝘄 Large 𝗕𝘂𝘆𝘀: $COP, $AMAT, $HAS 𝗗𝗢𝗨𝗕𝗟𝗘𝗗 position: $DHR 𝗦𝗢𝗟𝗗 out: $BILL Alex's portfolio is up 115.97% in the past 3 years. Source: https://hedgefollow.com/funds/Senator+Investment+Group
0 · Reply
peloswing
peloswing May. 13 at 3:39 PM
Someone Just Bought the Dip on $DHR $1.5 Million of September $185 Calls AT THE ASK!
0 · Reply
TheStockTraderHub
TheStockTraderHub May. 13 at 3:33 PM
$DHR long dated CALL BUYER spotted 🐂
0 · Reply
accretivewealth
accretivewealth May. 13 at 2:47 PM
$DHR There's Oversold, and then there's $DHR. Good night nurse!
0 · Reply
Latest News on DHR
Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

May 15, 2026, 1:00 AM EDT - 2 days ago

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

ABT ACN HD MCD MDT MKC RSG

Danaher resumed with an Outperform at RBC Capital

2026-05-14T20:49:09.000Z - 3 days ago

Danaher resumed with an Outperform at RBC Capital

Danaher Transcript: Bank of America Global Healthcare Conference 2026

May 13, 2026, 2:20 PM EDT - 4 days ago

Danaher Transcript: Bank of America Global Healthcare Conference 2026

Danaher to Present at Bank of America Securities Healthcare Conference

May 6, 2026, 4:15 PM EDT - 11 days ago

Danaher to Present at Bank of America Securities Healthcare Conference

Danaher Announces Quarterly Dividend

May 5, 2026, 4:30 PM EDT - 12 days ago

Danaher Announces Quarterly Dividend

Danaher Transcript: AGM 2026

May 5, 2026, 3:00 PM EDT - 12 days ago

Danaher Transcript: AGM 2026

Masimo shareholders approve acquisition by Danaher

2026-05-04T13:40:51.000Z - 13 days ago

Masimo shareholders approve acquisition by Danaher

MASI

Masimo Shareholders Approve Acquisition by Danaher

May 4, 2026, 9:00 AM EDT - 13 days ago

Masimo Shareholders Approve Acquisition by Danaher

MASI

Agilent appoints Michael Buckner as CLO

2026-05-04T12:32:30.000Z - 13 days ago

Agilent appoints Michael Buckner as CLO

A

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Apr 23, 2026, 1:39 PM EDT - 24 days ago

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Apr 22, 2026, 7:15 PM EDT - 25 days ago

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher price target lowered to $250 from $270 at UBS

2026-04-22T13:48:48.000Z - 25 days ago

Danaher price target lowered to $250 from $270 at UBS

Danaher price target lowered to $245 from $249 at Baird

2026-04-22T11:24:15.000Z - 25 days ago

Danaher price target lowered to $245 from $249 at Baird

Danaher price target lowered to $235 from $275 at Guggenheim

2026-04-22T11:18:47.000Z - 25 days ago

Danaher price target lowered to $235 from $275 at Guggenheim

Danaher price target raised to $245 from $240 at Jefferies

2026-04-21T18:11:29.000Z - 26 days ago

Danaher price target raised to $245 from $240 at Jefferies

Danaher Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 26 days ago

Danaher Earnings Call Transcript: Q1 2026

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Apr 21, 2026, 7:33 AM EDT - 26 days ago

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Danaher beats first-quarter profit estimates on strong bioprocessing demand

Apr 21, 2026, 7:28 AM EDT - 26 days ago

Danaher beats first-quarter profit estimates on strong bioprocessing demand

Options Volatility and Implied Earnings Moves Today, April 21, 2026

2026-04-21T11:05:26.000Z - 26 days ago

Options Volatility and Implied Earnings Moves Today, April 21, 2026

GE HAL ISRG MMM NLY NOC RTX

Danaher reports Q1 adjusted EPS $2.06, consensus $1.94

2026-04-21T10:09:06.000Z - 26 days ago

Danaher reports Q1 adjusted EPS $2.06, consensus $1.94

Danaher sees Q2 non-GAAP core revenue up in LSD percentage range y/y

2026-04-21T10:07:41.000Z - 26 days ago

Danaher sees Q2 non-GAAP core revenue up in LSD percentage range y/y

Danaher raises FY26 adjusted EPS view to $8.35-$8.55 from $8.35-$8.50

2026-04-21T10:06:16.000Z - 26 days ago

Danaher raises FY26 adjusted EPS view to $8.35-$8.55 from $8.35-$8.50

Danaher Reports First Quarter 2026 Results

Apr 21, 2026, 6:00 AM EDT - 26 days ago

Danaher Reports First Quarter 2026 Results

Danaher price target lowered to $249 from $251 at Baird

2026-04-17T10:46:47.000Z - 4 weeks ago

Danaher price target lowered to $249 from $251 at Baird

Danaher price target lowered to $205 from $220 at Rothschild & Co Redburn

2026-04-17T08:50:13.000Z - 4 weeks ago

Danaher price target lowered to $205 from $220 at Rothschild & Co Redburn

Danaher price target lowered to $230 from $250 at Barclays

2026-04-14T10:49:13.000Z - 4 weeks ago

Danaher price target lowered to $230 from $250 at Barclays

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

Apr 13, 2026, 3:01 AM EDT - 4 weeks ago

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Apr 9, 2026, 6:50 PM EDT - 5 weeks ago

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Danaher price target lowered, added to ‘Tactical Outperform’ list at Evercore

2026-04-06T12:01:15.000Z - 5 weeks ago

Danaher price target lowered, added to ‘Tactical Outperform’ list at Evercore

Danaher put volume heavy and directionally bearish

2026-03-25T15:35:15.000Z - 7 weeks ago

Danaher put volume heavy and directionally bearish

Danaher Schedules First Quarter 2026 Earnings Conference Call

Mar 20, 2026, 4:15 PM EDT - 2 months ago

Danaher Schedules First Quarter 2026 Earnings Conference Call

Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 1:50 PM EST - 2 months ago

Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Danaher to Present at TD Cowen Health Care Conference

Feb 24, 2026, 4:05 PM EST - 2 months ago

Danaher to Present at TD Cowen Health Care Conference

Danaher to buy Masimo for $9.9 billion

Feb 17, 2026, 8:04 AM EST - 3 months ago

Danaher to buy Masimo for $9.9 billion

MASI

Masimo to be Acquired by Danaher for $180.00 Per Share

Feb 17, 2026, 8:02 AM EST - 3 months ago

Masimo to be Acquired by Danaher for $180.00 Per Share

MASI

Danaher To Acquire Masimo Corporation

Feb 17, 2026, 8:00 AM EST - 3 months ago

Danaher To Acquire Masimo Corporation

MASI

Danaher Strikes $10 Billion Deal for Masimo

Feb 17, 2026, 6:09 AM EST - 3 months ago

Danaher Strikes $10 Billion Deal for Masimo

MASI

Danaher closes in on nearly $10 billion deal for Masimo, FT reports

Feb 16, 2026, 11:11 PM EST - 3 months ago

Danaher closes in on nearly $10 billion deal for Masimo, FT reports

MASI

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Feb 12, 2026, 12:30 PM EST - 3 months ago

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Danaher Earnings Call Transcript: Q4 2025

Jan 28, 2026, 8:00 AM EST - 3 months ago

Danaher Earnings Call Transcript: Q4 2025

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Jan 28, 2026, 7:08 AM EST - 3 months ago

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Danaher Reports Fourth Quarter and Full Year 2025 Results

Jan 28, 2026, 6:00 AM EST - 3 months ago

Danaher Reports Fourth Quarter and Full Year 2025 Results

Danaher Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 4 months ago

Danaher Transcript: 44th Annual J.P. Morgan Healthcare Conference

Danaher CEO to Comment on Financial Performance

Jan 12, 2026, 9:00 AM EST - 4 months ago

Danaher CEO to Comment on Financial Performance

The Big 3: BA, DHR, DG

Jan 8, 2026, 1:05 PM EST - 4 months ago

The Big 3: BA, DHR, DG

BA DG

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 8, 2026, 8:00 AM EST - 4 months ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Danaher to Present at J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:15 PM EST - 4 months ago

Danaher to Present at J.P. Morgan Healthcare Conference

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:48 AM EST - 5 months ago

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 17, 2025, 7:30 AM EST - 5 months ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

Dec 4, 2025, 12:15 PM EST - 5 months ago

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

DX HSY NLY BMEZ UTG

3 More Good Stocks to Invest In After Earnings

Nov 18, 2025, 4:29 PM EST - 6 months ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA

Danaher Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 6:00 AM EST - 6 months ago

Danaher Transcript: Jefferies London Healthcare Conference 2025

The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 6 months ago

The Big 3: TMO, DHR, VLO

TMO VLO

Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 6 months ago

Danaher to Present at Jefferies Global Healthcare Conference

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Oct 21, 2025, 10:55 AM EDT - 7 months ago

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Danaher Earnings Call Transcript: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 7 months ago

Danaher Earnings Call Transcript: Q3 2025

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Oct 21, 2025, 7:01 AM EDT - 7 months ago

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 7 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum

Danaher Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 7 months ago

Danaher Reports Third Quarter 2025 Results

Danaher Stock: Monopoly Margins, Discounted Price

Oct 15, 2025, 10:25 AM EDT - 7 months ago

Danaher Stock: Monopoly Margins, Discounted Price

4 Stocks That Aren't Too Hot to Buy Right Now

Oct 6, 2025, 2:45 PM EDT - 7 months ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 23, 2025, 4:15 PM EDT - 8 months ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Analysts' Top S&P 500 Stocks to Buy Now

Sep 11, 2025, 2:26 PM EDT - 8 months ago

Analysts' Top S&P 500 Stocks to Buy Now

HWM SPGI

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

Sep 10, 2025, 8:31 AM EDT - 8 months ago

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

Danaher Appoints Jonathan Leiken as General Counsel

Jul 31, 2025, 4:15 PM EDT - 10 months ago

Danaher Appoints Jonathan Leiken as General Counsel

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Jul 24, 2025, 8:08 PM EDT - 10 months ago

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

accretivewealth
accretivewealth May. 15 at 2:19 PM
$DHR Apparently, there is no bottom. Sometimes the market sends a message. Management does not always listen.
1 · Reply
accretivewealth
accretivewealth May. 14 at 6:56 PM
$DHR worse than paint drying, paint peeling here
0 · Reply
Wallstfan
Wallstfan May. 14 at 5:58 PM
$DHR here we go again, selling off back to red
0 · Reply
11thestate
11thestate May. 14 at 2:33 PM
$DHR — Danaher Corporation Agreed to Settle With Investors Danaher Corporation has agreed to settle $172.5 million with investors regarding its bioprocessing business, COVID-related demand assumptions, and repeated guidance cuts. The agreement has already been submitted to the court for final approval. The settlement aims to compensate affected shareholders. If you purchased $DHR between January 27, 2022, and October 23, 2023, you may be eligible to file a claim and recover part of your losses. You can review the details and submit your claim here: https://11th.com/cases/danaher-investor-settlement
2 · Reply
Wallstfan
Wallstfan May. 14 at 1:00 PM
$DHR great company on sale. If it’s not tech there just selling everything. At some point the rotation will come. Slowly taking a position here.
1 · Reply
dka79
dka79 May. 14 at 11:51 AM
$DHR reversal coming ?
1 · Reply
HedgeFollow
HedgeFollow May. 14 at 11:23 AM
🔍 𝗡𝗲𝘄 13𝗙 𝗥𝗲𝗹𝗲𝗮𝘀𝗲𝗱 🔎 Outstanding Hedge Fund Manager Alex Klabin of Senator Group made some Notable trades in Q1: 𝗡𝗲𝘄 Large 𝗕𝘂𝘆𝘀: $COP, $AMAT, $HAS 𝗗𝗢𝗨𝗕𝗟𝗘𝗗 position: $DHR 𝗦𝗢𝗟𝗗 out: $BILL Alex's portfolio is up 115.97% in the past 3 years. Source: https://hedgefollow.com/funds/Senator+Investment+Group
0 · Reply
peloswing
peloswing May. 13 at 3:39 PM
Someone Just Bought the Dip on $DHR $1.5 Million of September $185 Calls AT THE ASK!
0 · Reply
TheStockTraderHub
TheStockTraderHub May. 13 at 3:33 PM
$DHR long dated CALL BUYER spotted 🐂
0 · Reply
accretivewealth
accretivewealth May. 13 at 2:47 PM
$DHR There's Oversold, and then there's $DHR. Good night nurse!
0 · Reply
briefingcom
briefingcom May. 13 at 12:37 PM
$DHR: Danaher unit Cepheid receives IVDR CE mark for multiplex gastrointestinal test panel https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260513041937DHR&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
DosGatos
DosGatos May. 12 at 5:46 PM
$DHR Execs & Upper Mgmt should be put on a PIP!
1 · Reply
Quant73
Quant73 May. 12 at 4:14 PM
$ISRG Great breakdown of whats happening with $IHI stocks on Griffonomics. $WAT $DHR $SYK Very Bullish for $ISRG https://www.youtube.com/watch?v=7jv0vDOmlV8
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 3:57 PM
$DHR Share Price: $167.16 Contract Selected: Jun 05, 2026 $175 Calls Buy Zone: $1.87 – $2.31 Target Zone: $3.52 – $4.30 Potential Upside: 78% ROI Time to Expiration: 23 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER May. 12 at 3:06 PM
$BSX sector rotation helping here $IHI $MDT $ABT $DHR
0 · Reply
Popo_Jijo
Popo_Jijo May. 11 at 3:02 PM
$DHR the market can already smell a masimo write down.
2 · Reply
ErosROI
ErosROI May. 10 at 6:29 PM
$DHR what's next support area
1 · Reply
BioTechHealthX
BioTechHealthX May. 10 at 4:55 PM
$DHR Danaher Corporation may not be chasing one miracle drug, but that is exactly why DHR deserves attention. With bioprocessing tools, lab technologies, consumables, and strong cash flow, Danaher gives investors a steadier way to play the biotech and life sciences boom without betting everything on one clinical trial. https://biotechhealthx.com/biotech-news/is-now-the-best-time-to-invest-in-danaher-corporation-dhr/
0 · Reply
BioTechHealthX
BioTechHealthX May. 10 at 4:31 AM
$ARGX $MRNA $UTHR $VRTX $DHR Biotech stocks can move fast when clinical trials, FDA approvals, product sales, and investor momentum line up. These top 5 best biotech stocks to watch now could attract attention as healthcare innovation heats up in 2026. https://biotechhealthx.com/biotech-news/top-5-best-biotech-stocks-to-watch-now/
1 · Reply
PickAlpha
PickAlpha May. 8 at 4:35 PM
6/6: EPA signals proposal to soften parts of Biden PFAS drinking-water rule: keep 4 ppt PFOA/PFOS but extend compliance deadline to 2031; rescind/revisit other PFAS limits (docket TBD) $PHO $FIW $XYL $DHR $WM
0 · Reply
Popo_Jijo
Popo_Jijo May. 8 at 4:27 PM
$DHR fresh s&p 500 all-time highs. fresh danaher 52-week lows. where all them rainer fanboys at that think this is only about the sector and not about leadership?
1 · Reply
BillionerOfKing
BillionerOfKing May. 8 at 5:23 AM
$DHR Current Stock Price: $175.70 Contracts to trade: $175.0 DHR May 08 2026 Call Entry: $1.12 Exit: $2.20 ROI: 95% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply